Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

ClinicalTrials.gov ID: NCT00363116

Public ClinicalTrials.gov record NCT00363116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Comparative Trial of Two Daclizumab Dosing Strategies Versus No Induction Treatment in Combination With Tacrolimus, Mycophenolate Mofetil, and Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

Study identification

NCT ID
NCT00363116
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
University of Cincinnati
Other
Enrollment
298 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 1999
Primary completion
Nov 30, 2004
Completion
Nov 30, 2004
Last update posted
Oct 24, 2013

1999 – 2004

United States locations

U.S. sites
23
U.S. states
18
U.S. cities
22
Facility City State ZIP Site status
University of California - Davis Davis California 95616
University of California - Los Angeles Los Angeles California 90095
Washington Hospital Washington D.C. District of Columbia 20010
University of Miami Miami Florida 33124
Emory University Atlanta Georgia 30322
Northwestern University Chicago Illinois 60208
University of Chicago Chicago Illinois 60637
University of Iowa Iowa City Iowa 52242
University of Maryland College Park Maryland 20742
University of Minnesota Minneapolis Minnesota 55455
Cornell University Ithaca New York 14853
Carolina Medical Center Charlotte North Carolina 28203
Duke University Durham North Carolina 27708
Ohio State University Columbus Ohio 43210
Oregon Health Science University Portland Oregon 97239
Medical University of South Carolina Charleston South Carolina 29425
University of Tennessee Memphis Tennessee 38163
University of Texas - Houston Houston Texas 77030
Baylor University Waco Texas 76798
Medical College of Virginia Richmond Virginia 23298
University of Washington Seattle Washington 98195
University of Wisconsin Madison Wisconsin 53705
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00363116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00363116 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →